Sandoz Group AG (0SAN) is a Medical pharmaceuticals company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for Sandoz Group AG in 2026. The next earnings report is expected on March 17, 2027.
Next earnings date
17 Mar 2027
In 209 days
EPS estimate
2.29
Revenue estimate
6.4B
Past earnings
Latest earnings analysis
Sandoz Group AG missed consensus estimates in its latest earnings report, with EPS of USD 1.71 falling 1.2% short of expectations and revenue of USD 5.76 billion meeting estimates with a 0.0% surprise. In the previous report EPS came in ahead of expectations while revenue was below estimates.
Next ex-dividend
—
Not scheduled
Next payment
—
Not scheduled
Dividend amount
—
Not available
Past dividends
| Ex-dividend | Payment | Amount |
|---|---|---|
| 13 Apr 2026 | 15 Apr 2026 | 1.02 |
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
Sandoz Group AG (0SAN) is scheduled to report earnings on March 17, 2027.
Sandoz Group AG (0SAN) last reported earnings on August 5, 2026.
Sandoz Group AG (0SAN) is listed on London Exchange.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.